Sara L Kroll1, Emilija Nikolic2, Franziska Bieri2, Michael Soyka3,4, Markus R Baumgartner5, Boris B Quednow6,7. 1. Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital of the University of Zurich, Lenggstrasse 31, PO Box 1931, 8008, Zurich, Switzerland. saraliane.kroll@bli.uzh.ch. 2. Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital of the University of Zurich, Lenggstrasse 31, PO Box 1931, 8008, Zurich, Switzerland. 3. Psychiatric Hospital of the University of Munich, Nussbaumstrasse 7, 80336, Munich, Germany. 4. Medical Park Chiemseeblick, Rasthaustrasse 25, 83233, Bernau am Chiemsee, Germany. 5. Center for Forensic Hair Analysis, Institute of Forensic Medicine, University of Zurich, Kurvenstrasse 17, 8006, Zurich, Switzerland. 6. Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital of the University of Zurich, Lenggstrasse 31, PO Box 1931, 8008, Zurich, Switzerland. quednow@bli.uzh.ch. 7. Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland. quednow@bli.uzh.ch.
Abstract
RATIONALE: Non-medical prescription opioid use (NMPOU) has become a major public health issue in the USA and is also increasing in Europe. However, little is known about neuropsychological associations of NMPOU-specifically regarding social cognition, which is essential for social functioning and treatability of opioid dependence. Previous studies with heroin users and opioid-substituted patients reported deficits in various cognitive functions, but these results are likely confounded by comorbid physical and psychiatric diseases, overdose-associated hypoxia, and adulteration of street heroin. Therefore, the purpose of the present study was to investigate social and non-social cognition in a relatively pure NMPOU sample taking opioid analgesics or antitussives. METHODS: We assessed 23 individuals with NMPOU objectively confirmed by hair analyses and 29 opioid-naïve, healthy controls, employing a comprehensive neuropsychological test battery. RESULTS: Significant impairments were found between NMPOU individuals and controls regarding the cognitive domains of attention (p < .01, Hedge's g = .85), declarative memory (p < .05, g = .66), and global cognitive empathy (p < .01, g = 0.99)-the latter included problems with emotion recognition from faces, voices, and complex scenes. Opioid hair concentrations transformed to morphine equivalents were negatively correlated with global cognitive empathy (r = - 0.52, p < .01), suggesting dose-dependent deficits. CONCLUSION: In contrast to stimulant users primarily displaying deficits in emotional empathy, opioid users showed relatively selective impairments in measures of cognitive empathy, with dose-dependent effects suggesting potential opioid-induced deficits and involvement of the opioid-system in processes of cognitive empathy. These results have important implications for future interventions of opioid dependence targeting social functioning and consequently enhancing therapy outcome and preventing relapse.
RATIONALE: Non-medical prescription opioid use (NMPOU) has become a major public health issue in the USA and is also increasing in Europe. However, little is known about neuropsychological associations of NMPOU-specifically regarding social cognition, which is essential for social functioning and treatability of opioid dependence. Previous studies with heroin users and opioid-substituted patients reported deficits in various cognitive functions, but these results are likely confounded by comorbid physical and psychiatric diseases, overdose-associated hypoxia, and adulteration of street heroin. Therefore, the purpose of the present study was to investigate social and non-social cognition in a relatively pure NMPOU sample taking opioid analgesics or antitussives. METHODS: We assessed 23 individuals with NMPOU objectively confirmed by hair analyses and 29 opioid-naïve, healthy controls, employing a comprehensive neuropsychological test battery. RESULTS: Significant impairments were found between NMPOU individuals and controls regarding the cognitive domains of attention (p < .01, Hedge's g = .85), declarative memory (p < .05, g = .66), and global cognitive empathy (p < .01, g = 0.99)-the latter included problems with emotion recognition from faces, voices, and complex scenes. Opioid hair concentrations transformed to morphine equivalents were negatively correlated with global cognitive empathy (r = - 0.52, p < .01), suggesting dose-dependent deficits. CONCLUSION: In contrast to stimulant users primarily displaying deficits in emotional empathy, opioid users showed relatively selective impairments in measures of cognitive empathy, with dose-dependent effects suggesting potential opioid-induced deficits and involvement of the opioid-system in processes of cognitive empathy. These results have important implications for future interventions of opioid dependence targeting social functioning and consequently enhancing therapy outcome and preventing relapse.
Authors: Jarred W Younger; Larry F Chu; Nicole T D'Arcy; Kiley E Trott; Laura E Jastrzab; Sean C Mackey Journal: Pain Date: 2011-04-30 Impact factor: 6.961
Authors: Matthias Vonmoos; Lea M Hulka; Katrin H Preller; Daniela Jenni; Markus R Baumgartner; Rudolf Stohler; Karen I Bolla; Boris B Quednow Journal: Br J Psychiatry Date: 2013-05-23 Impact factor: 9.319
Authors: Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones Journal: Ann Intern Med Date: 2017-08-01 Impact factor: 25.391
Authors: T J Ornstein; J L Iddon; A M Baldacchino; B J Sahakian; M London; B J Everitt; T W Robbins Journal: Neuropsychopharmacology Date: 2000-08 Impact factor: 7.853
Authors: Lea M Hulka; Katrin H Preller; Matthias Vonmoos; Sarah D Broicher; Boris B Quednow Journal: Front Psychiatry Date: 2013-09-05 Impact factor: 4.157
Authors: Ann-Kathrin Kexel; Matthias Vonmoos; Katrin H Preller; Lea M Hulka; Erich Seifritz; Boris B Quednow Journal: Front Psychiatry Date: 2020-06-30 Impact factor: 4.157
Authors: Seven E Tomek; Gabriela M Stegmann; Jonna M Leyrer-Jackson; Jose Piña; M Foster Olive Journal: Soc Neurosci Date: 2020-03-30 Impact factor: 2.083